论文信息 - Second malignancies in patients with essential thrombocythaemia. - 字舞流文

Second malignancies in patients with essential thrombocythaemia.

F. Fabris | A. Girolami | M. Randi

[1] T. Barbui,et al. Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long‐term follow‐up of a randomized clinical trial , 2000, British journal of haematology.

[2] F. Fabris,et al. Leukemia and Myelodysplasia Effect of Multiple Cytotoxic Therapy in Essential Thrombocythemia , 2000, Leukemia & lymphoma.

[3] J. Laszlo,et al. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. , 1997, Seminars in hematology.

[4] T. Barbui,et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. , 1995, The New England journal of medicine.